Affordable Access

deepdyve-link
Publisher Website

THE RELATIONSHIP OF BRAF V600E MUTATION STATUS TO FDG PET/CT AVIDITY IN THYROID CANCER: A REVIEW AND META-ANALYSIS.

Authors
  • Santhanam, Prasanna1
  • Khthir, Rodhan2
  • Solnes, Lilja B3
  • Ladenson, Paul W1
  • 1 From: 1Division of Endocrinology, Diabetes, & Metabolism, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA-21287.
  • 2 Division of Endocrinology, Diabetes, & Metabolism, Department of Medicine, Joan C Edwards School of Medicine, Huntington,WV-25701.
  • 3 Section of Nuclear Medicine, Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, MD, USA-21287.
Type
Published Article
Journal
Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
Publication Date
Nov 16, 2017
Identifiers
DOI: 10.4158/EP-2017-0080
PMID: 29144823
Source
Medline
Keywords
License
Unknown

Abstract

BRAF= B-Raf proto-oncogene, serine/threonine kinase; FDG = Fluorodeoxyglucose; PET = Positron Emission Tomography; CT = Computerized Tomography; SUV = Standardized Uptake Values; GLUT = Glucose Transporter.

Report this publication

Statistics

Seen <100 times